Inhibition of pancreatic cholesterol esterase reduces cholesterol absorption in the hamster

BMC Pharmacology

Volumn 4, Issue , 2004, Pages

  Heidrich, John E ^a   Contos, Linda M ^a   Hunsaker, Lucy A ^b   Deck, Lorraine M ^c   Vander Jagt, David L ^b  

^a University of New Mexico   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 CHLORO 3 (1 ETHYL 2 CYCLOHEXYL) 2 PYRONE; CHOLESTEROL; CHOLESTEROL ESTER; CHOLESTEROL ESTERASE; CHOLESTEROL ESTERASE INHIBITOR; CHOLESTEROL OLEATE; CHOLIC ACID; ENZYME INHIBITOR; PANCREAS ENZYME; PROTON; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL INTAKE; CHOLESTEROL LIVER LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; ENZYME INHIBITION; FEEDING; HAMSTER; HISTOPATHOLOGY; INTESTINE CELL; ISOTOPE LABELING; LIPID ABSORPTION; LIPID HYDROLYSIS; MICELLE; NONHUMAN; TOXICITY TESTING; URINALYSIS;

ANIMALS; CHOLESTEROL ESTERS; CHOLESTEROL, DIETARY; CRICETINAE; ENZYME INHIBITORS; HYDROLYSIS; INTESTINAL ABSORPTION; MALE; PYRONES; STEROL ESTERASE;

EID: 2642548240     PISSN: 14712210     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2210-4-5     Document Type: Article

References (39)

1. Gordon T, Kannel WB, Castelli WP, Dawber TR: Lipoproteins, cardiovascular disease, and death: the Framingham Study. Arch Intern Med 1981, 141:1128-1131.
2. Hsu I, Spinler SA, Johnson NE: Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia. Ann Pharmacotherapy 1995, 29:743-759.
3. Boumendil E, Tubert-Bitter P: Depression-induced absenteeism in relation to antihyperlipidemic treatment: a study using GAZEL cohort data. Epidemiology 1995, 6:322-325.
4. Phan T, McLeod JG, Pollard JD, Peiris O, Rohan A, Halpern JP: Peripheral neuropathy associated with simvastatin. J Neurology Neurosurgery & Psychiatry 1995, 58:625-628.
5. Proksch E: Antilipemic drug-induced skin manifestations. Hautartz 1995, 46:76-80.
6. Myers-Payne SC, Hui DY, Brockman HL, Schroeder F: Cholesterol esterase: a cholesterol transfer protein. Biochem 1995, 34:3942-3947.
7. Howles PN, Carter CP, Hui DY: Dietary free and esterified cholesterol absorption in cholesterol esterase (bile salt-stimulated lipase) gene-targeted mice. J Biol Chem 1996, 271:7196-7202.
8. Bailey JM, Gallo L, Gillespie J: Inhibition of dietary cholesterol ester absorption by 3-BCP, a suicide inhibitor of cholesterolesterase. Biochem Soc Trans 1995, 23:408S.
9. Daniels SB, Cooney E, Sofia MJ, Chakravarty PK, Katzenellenbogen JA: Haloenol lactones: potent enzyme-activated irreversible inhibitors for a-chymotrypsin. J Biol Chem 1983, 250:
10. Deck LM, Baca ML, Salas SL, Hunsaker LA, Vander Jagt DL: 3-Alkyl-6-chloro-2-pyrones: Selective inhibitors of pancreatic cholesterol esterase. J Med Chem 1999, 42:4250-4256.
11. Nilsson J, Blackberg L, Carlsson P, Enerback S, Hernell O, Bjursell G: cDNA cloning of human-milk bile-salt-stimulated lipase and evidence for its identity to pancreatic carboxylic ester hydrolase. Eur J Biochem 1990, 192:543-550.
12. Brodt-Eppley J, White P, Jenkins S, Hui DY: Plasma cholesterol esterase level is a determinant for an atherogenic lipoprotein profile in normolipidemic human subjects. Biochim Biophys Acta 1995, 1272:69-72.
13. Li F, Hui DY: Modified low density lipoprotein enhances the secretion of bile salt-stimulated cholesterol esterase by human monocyte-macrophages: species-specific differences in macrophage cholesteryl ester hydrolase. J Biol Chem 1997, 272:28666-28671.
14. Holtsberg FW, Ozgur LE, Garsetti DE, Myers J, Egan RW, Clark MA: Presence in human eosinophils of a lysophospholipase similar to that found in the pancreas. Biochem J 1995, 309:141-144.
15. Li F, Hui DY: Synthesis and secretion of the pancreatic-type carboxyl ester lipase by human endothelial cells. Biochem J 1998, 329:675-679.
16. Winkler KE, Harrison EH, Marsh JB, Glick JM, Ross AC: Characterization of a bile salt-dependent cholesteryl ester hydrolase activity secreted from HepG2 cells. Biochim Biophys Acta 1992, 1126:151-158.
17. Krause BR, Sliskovic DR, Anderson M, Homan R: Lipid-lowering effects of WAY-121,898, an inhibitor of pancreatic cholesteryl ester hydrolase. Lipids 1998, 33:489-498.
18. Lindquist S, Blackberg L, Hernell O: Distribution of the bile-salt-stimulated lipase in human tissues. FASEB 2001, 15:A193.
19. Jeon SM, Kim HS, Lee TG, Ryu SH, Suh PG, Byun SJ, Park YB, Choi MS: Lower absorption of cholesteryl oleate in rats supplemented with areca catechu L. extract. Ann Nutr Metab 2000, 44:170-176.
20. Borja CR, Vahouny GV, Treadwell CR: Role of bile and pancreatic juice in cholesterol absorption and esterification. Am J Physiol 1964, 206:223-228.
21. Gallo LL, Clark SB, Myers S, Vahouny GV: Cholesterol absorption in rat intestine: Role of cholesterol esterase and acyl coenzyme A:cholesterol acyltransferase. J Lipid Res 1984, 25:604-612.
22. Lopez-Candales A, Bosner MS, Spilburg CA, Lange LG: Cholesterol transport function of pancreatic cholesterol esterase: Directed sterol uptake and esterification in enterocytes. Biochemistry 1993, 32:12085-12089.
23. Bhat SG, Brockman HL: The role of cholesteryl ester hydrolysis and synthesis in cholesterol transport across rat intestinal mucosal membrane. A new concept. Biochem Biophys Res Comm 1982, 109:486-492.
24. Huang Y, Hui DY: Metabolic fate of pancreas-derived cholesterol esterase in intestine: An in vivo study using Caco-2 cells. J Lipid Re 1990, 31:2029-2037.
25. Shamir R, Johnson WJ, Zolfaghari R, Lee HS, Fisher EA: Role of bile salt-dependent cholesteryl ester hydrolase in the uptake of micellar cholesterol by intestinal cells. Biochemistry 1995, 34:6351-6358.
26. Spilburg CA, Cox DG, Wang X, Bernat BA, Bosner MS, Lange LG: Identification of a species specific regulatory site in human pancreatic cholesterol esterase. Biochemistry 1995, 34:3942-3947.
27. Bosner MS, Wolff AA, Ostlund RE Jr: Lack of effect of cholesterol esterase inhibitor CVT-1 on cholesterol absorption and LDL cholesterol in humans. Cardiovasc Drugs Ther 1999, 13:449-454.
28. Ikeda I, Matsuoka R, Hamada T et al.: Cholesterol esterase accelerates intestinal cholesterol absorption. Biochim Biophys Acta 2002, 1571:34-44.
29. 2 relieves phosphatidylcholine inhibition of micellar cholesterol absorption and transportby human intestinal cell line Caco-2. J Lipid Res 1998, 39:1197-1209.
30. Feaster SR, Quinn DM: Mechanism-based inhibitors of mammalian cholesterol esterase. Methods Enzymol 1997, 286:231-252.
31. Feaster SR, Lee K, Baker N, Hui DY, Quinn DM: Molecular recognition by cholesterol esterase of active site ligands: structure-activity effects for inhibition by aryl carbamates and subsequent carbamylenzyme turnover. Biochemistry 1996, 35:16723-16734.
32. Lin G, Shieh C-T, Ho H-C, Chouhwang J-Y, Lin W-Y, Lu C-P: Structure-reactivity relationships for the inhibition mechanism at the second alkyl-chain-binding site of cholesterol esterase and lipase. Biochemistry 1999, 38:9971-9981.
33. Gelb MH, Abeles RH: Mechanism of inactivation of chymotrypsin by 3-benzyl-6-chloro-2-pyrone. Biochemistry 1984, 23:6596-6604.
34. Ringe D, Mottonen JM, Gelb MH, Abeles RH: X-ray diffraction analysis of the inactivation of chymotrypsin by 3-benzyl-6-chloro-2-pyrone. Biochemistry 1986, 25:5633-5638.
35. Ringe D, Seaton BA, Gelb MH, Abeles RH: Inactivation of chymotrypsin by 5-benzyl-6-chloro-2-pyrones: 13C NMR and X-ray diffraction analysis of the inactivator-enzyme complex. Biochemistry 1985, 24:64-68.
36. Powers JC, Kam CM: Isocoumarin inhibitors of serine peptidases. Methods Enzymol 1994, 244:442-457.
37. Daniels SB, Katzenellenbogen JA: Haloenol-lactones: studies on the mechanism of inactivation of alpha-chymotrypsin. Biochemistry 1986, 25:1436-1444.
38. Harwood HJ Jr, Chandler CE, Pellarin LD, Bangerter FW, Wilkins RW, Long CA, Cosgrove PC, Malinow MR, Marzetta CA, Pettini JL, Savoy YE, Mayne JT: Pharmocological consequencess of cholesterol absorption inhibition: alteration in cholesterol metabolism and reduction in plasma cholesterol concentration induced by the synthetic saponin B-tigogenin cellbioside (CP-88,818 tiqueside). J Lipid Res 1993, 34:377-395.
39. DeNinno MP, McCarthy PA, Duplantier KC, Eller C, Etienne JB, Zawistoski MP, Bangerter FW, Chandler CE, Morehouse LA, Sugarman ED, Wilkins RW, Woody HA, Zaccaro LM: Steroidal Glycoside Cholesterol Absorption Inhibitors. J Med Chem 1997, 40:2547-2555.